This week saw the launch of new pharmacy super banner group
The federal government announced four new priority areas for phase 2 of the Pharmacy Trial Program.
The new trial areas will include: disease management of appropriate conditions; medicines management and reconciliation services at the point of transition between care sectors; new and innovative community pharmacist outreach services to residential aged care facilities; and screening and referral for cardiovascular risk.
Federal Minister for Health Sussan Ley said she supported moves to downschedule to S3 some prescription medicines such as a number of influenza, migraine and UTI treatments. She also flagged a final decision on codeine rescheduling before the end of the year.
The Pharmacy Guild responded this week to media reports that Ramsay Health Care is set to open a Melbourne pharmacy by pointing out that community pharmacies must be owned by registered pharmacists.
Guild national president George Tambassis said “It is critical that community pharmacies continue to be owned and controlled by practising professional pharmacists rather than big corporates which, by law, must put their shareholders first”.
Federal Parliament heard first hand of the success of the Hepatitis C PBS program, with Department of Health informing the Senate Estimates hearing that since 1 March 25,000 patients have received these medications.To date, 5000 of these patients have completed their course of treatment.
Pharmacies were reminded to protect their IT systems against the ongoing threat of ransomware attacks during the week. Regulators say they continue to receive reports of pharmacies beign targeted by this “malicious software that handicaps computer functionality”.
Meanwhile, PDL, owners of AJP, farewelled CEO Marie Ritchie after a distinguished and successful 22 year tenure.